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Inflammatory fibroid polyps (IFP) are benign 
mesenchymal tumors which originate from the 
submucosa of the stomach or the small bowel. IFP 
occur rarely in the colon and in the esophagus. 
In 1949 the Czech pathologist Josef Vanek reported on 
six cases of gastric lesion which he referred to as 
gastric submucosal granuloma with eosinophilic 
infiltration: "A peculiar lesion was observed consisting 
of more or less loose collagenous tissue with 
fibroblasts, lymphocytes, and eosinophilic 
polymorphonuclear leukocytes. The pathologic tissue 
thus composed appeared as a circumscribed focus in 
the submucosa, spreading toward the mucosa of the 
stomach. Macroscopically, it caused a bulging of the
mucosa, and in some cases even a polypous formation." 
(Vanek, 1949). 
At the same time the German pathologist Franz Bolck 
noticed these lesions, too, and referred to them as 
granuloblastoma of the stomach (for review see: Bolck 
and Katenkamp, 1982). The term inflammatory fibroid 
polyp was introduced four years after the initial 
description (Helwig and Ranier, 1953). Since then 
several hundred reports, mainly case series and reports 
on single cases, have been published which 
predominantly focussed on clinical and morphologic 
aspects. Notably, inflammatory fibroid polyps have 
been regarded as reactive lesions for decades. In 2008, 
however, the neoplastic nature of IFP became evident 
by the detection of activating PDGFRA mutations in 
these tumors (Schildhaus et al., 2008). 
Classification 
Note 
Inflammatory fibroid polyps are mesenchymal tumors 
of unknown lineage.  
Since some tumors tend to show considerable collagen 
production some authors have postulated a fibroblastic 
lineage. IFP are clearly distinct from gastrointestinal 
stromal tumors by their morphology, submucosal origin 
and clinical behavior although both entities share 
common mutational subtypes of the PDGFRA gene. 
IFP are benign. So far local recurrences have been 
described only anecdotally.  
No convincing case with invasive growth or aggressive 
outcome has been reported. 
Classification 
Benign mesenchymal tumor of the gastrointestinal 
tract. 
Clinics and pathology 
Phenotype / cell stem origin 
A progenitor cell of inflammatory fibroid polyps has 
not yet been established.  
However, Lasota et al. have discussed whether 
specialized PDGF dependent mesenchymal progenitor 
cells in the so-called villus clusters might represent 
progenitors (Lasota et al., 2009). 
Etiology 
Historically, IFP have been thought to represent a 
reactive inflammatory lesion.  
It was assumed that IFP might be associated for 
example with helicobacter infection or type A gastriti .  
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Inflammatory fibroid polyp of the stomach. Histological appearance of the "classic" (gastric) type with heavy inflammatory infiltrate. 
 
After discovery of the activating PDGFRA mutations 
in these tumors it became apparent that IFP represent 
true neoplasms which are - so far as we know today - 
obviously driven by activating mutations in the 
PDGFRA gene. 
Epidemiology 
Inflammatory fibroid polyps are rare lesions which 
affect predominantly adults. Notably, the mean age of 
patients with gastric tumors is significantly higher 
compared with IFP of the small bowel (72 years vs. 53 
years) (Huss et al., 2012). IFP account for 0.1 - 3.0 % 
of all gastric polyps (Carmack et al., 2009). 
Clinics 
Inflammatory fibroid polyps arise from the submucosa 
and tend to form polypoid lesions. They occur 
predominantly in the stomach (mainly in the antrum 
region). Most IFP remain undiagnosed for a long time 
or are incidental findings at endoscopy. Larger poly s 
tend to erode and ulcerate superficially with local 
bleeding representing the most common clinical 
symptom. Very rarely large tumors of several 
centimeters size have led to obstruction of the pylorus 
or the upper gastric sphincter. Most inflammatory 
fibroid polyps, however, are small measuring only few 
millimeters. 
IFP of the small bowel may also give rise to local  
bleeding. Major complications in this location, 
however, are intussusceptions and invaginations. At 
least in adolescents and adults, IFP are a frequent cause 
of this severe and acute disease. 
Inflammatory fibroid polyps are benign and do not 
recur nor metastasize. 
Pathology 
Inflammatory fibroid polyps are mostly small lesions of 
only few millimeters size. We have, however, seen 
some tumors of up to 10 centimeters (Huss et al., 
2012). IFP characteristically arise from the submucosa 
and grow through the lamina propria towards the 
surface of the mucosa where typically an ulceration is 
found.  
IFP consist of bland spindled cells which are 
characteristically arranged in whorls or in an onion skin 
like fashion around blood vessels or mucosal glands. 
The matrix consists of fine fibrillar collagen but might 
also be collagen-rich. 
The "classic" (or gastric) type which was originally 
described by Josef Vanek is characterized by a heavy 
inflammatory infiltrate which is rich in eosinophilic 
granulocytes. These lesions show a plenty of spindle 
cells but only little collagen. 
We and others have shown that there is another 
morphological subtype ("intestinal type") which, in
contrast, is paucicellular and collagen-rich.  
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Both cellular elements, fibroblastic spindle cells and 
inflammatory infiltrate, are less numerous. These 
tumors tend to be larger than those of the gastric type
(Huss et al., 2012). 
Outside of ulcerations no necroses are found. There is 
no considerable proliferative activity as mitoses of the 
spindle cell are almost never seen and Ki67 is below 
1%. 
Immunohistochemically, the spindle cells are mostly 
positive for CD34 but this feature may be absent 
especially in the intestinal type. PDGFRA expression is 
frequently found. Immunostains for KIT, DOG-1 as 
well as S100 and EMA are consistently negative. This 
may be important in the differential diagnosis of 
gastrointestinal stromal tumors, perineuriomas and 
other spindle cell lesions of the gastrointestinal tract. 
Treatment 
Most inflammatory fibroid polyps can be 
endoscopically removed. Only rarely surgery is 
necessary. 
Prognosis 
Benign tumor, no risk for an aggressive clinical 
behavior. Patient may, however, suffer from severe 




Activating mutations in exon 12, 14 and 18 of 
PDGFRA (platelet derived growth factor alpha) are th  
only known genetic alterations in inflammatory fibroid 
polyps. 





In the first genetic study of inflammatory fibroid polyps 
16 out of 23 lesions showed mutations in PDGFRA 
(Schildhaus et al., 2008). This finding could be 
confirmed shortly after the first description by a second 
independent study (Lasota et al., 2009), and meanwhile 
four series and one case report with molecular analyses 
have been published covering a total of 145 IFP (for 
review see: Huss et al., 2012). The frequency of 
mutations among the case series ranged from 21.7% to 
69.6%, obviously at least partially depending on the
methodology used. Additionally, the tumor cell content 
may contribute to differences in the frequency of 
mutations since many IFP contain only few lesional 
cells in a background of heavy inflammation or are 
considerably small. 
Activating PDGFRA mutations occur in exons 12, 14 
and 18. A genotype - phenotype correlation could be 
established in terms of tumor location as gastric IFP
harbor significantly more frequent exon 18 mutations. 
Exon 12 mutations are, however, associated with small 
bowel lesions. So far, only  
two cases with exon 14 mutations have been described, 
one originating from the small bowel the other from the 
stomach. 
Mutational types vary; there are point mutations as well 
as duplications and complex delins mutations. One 
mutational hot spot in IFP includes codons 567-571 of 
PDGFRA (exon 12) with p.566_571delinsR 
representing the most frequent subtype. Another 
frequently found mutation is a single nucleotide 
substitution in exon 18 (p.D842V). 
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